Soltego Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Soltego General Information
Description
Developer of a biopharmaceutical platform intended to help people protect their skin against UV-induced skin damage. The company's platform offers products that leverage skin pigmentation power for therapeutic and aesthetic applications by using topical formulations to enhance skin health, enabling consumers to get a safe, sunless tan for all skin types without chemicals or color additives.
Contact Information
Website
www.soltego.comCorporate Office
- 510 Ward Street
- Newton, MA 02459
- United States
Corporate Office
- 510 Ward Street
- Newton, MA 02459
- United States
Soltego Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 13-Nov-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 25-Apr-2019 | Completed | Generating Revenue |
Soltego Comparisons
Industry
Financing
Details
Soltego Competitors (9)
One of Soltego’s 9 competitors is COOLA, a Corporate Backed or Acquired company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| COOLA | Corporate Backed or Acquired | Carlsbad, CA | ||||
| Suvara | Corporation | West Long Branch, NJ | ||||
| Vita Liberata | Formerly PE-Backed | Ballyclare, United Kingdom | ||||
| TanOrganic | Formerly Angel backed | Dublin, Ireland | ||||
| Bondi Sands | Corporate Backed or Acquired | Elsternwick, Australia |
Soltego Patents
Soltego Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023272873-A1 | Pyrimidopyrimidone compounds and methods of use thereof | Pending | 17-May-2022 | ||
| EP-4526307-A1 | Pyrimidopyrimidone compounds and methods of use thereof | Pending | 17-May-2022 | ||
| EP-4526307-A4 | Pyrimidopyrimidone compounds and methods of use thereof | Pending | 17-May-2022 | ||
| JP-2025517351-A | Pyrimidopyrimidone compounds and methods of use thereof | Pending | 17-May-2022 | ||
| US-20250340556-A1 | Pyrimidopyrimidone compounds and methods of use thereof | Pending | 17-May-2022 | C07D487/04 |
Soltego Signals
Soltego Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bioincubator | Accelerator/Incubator | |||
| Angel (individual) | Minority |
Soltego FAQs
-
When was Soltego founded?
Soltego was founded in 2017.
-
Where is Soltego headquartered?
Soltego is headquartered in Newton, MA.
-
What is the size of Soltego?
Soltego has 4 total employees.
-
What industry is Soltego in?
Soltego’s primary industry is Personal Products.
-
Is Soltego a private or public company?
Soltego is a Private company.
-
What is Soltego’s current revenue?
The current revenue for Soltego is .
-
How much funding has Soltego raised over time?
Soltego has raised $7.34M.
-
Who are Soltego’s investors?
Bioincubator and have invested in Soltego.
-
Who are Soltego’s competitors?
COOLA, Suvara, Vita Liberata, TanOrganic, and Bondi Sands are some of the 9 competitors of Soltego.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process